Tuesday, October 22, 2024 2:52:38 PM
I think it’s simple. Reimbursement and funding are different.
LP made very clear they still have to do a global economic model in order to make a reimbursement request through the NICE STA process. It’s not easy but she hoped the whole process might be completed within 12 or less months (I assume she was including decision in that time frame.)
Meanwhile, if you can’t put your global economic model immediately together because you are awaiting some data (perhaps from compassionate program), it may be they could pursue alternative “funding” like the CDF, while they await the ability to assimilate a global economic model which would allow them to request “reimbursement.” IMHO.
Funding is different than reimbursement. Hopefully they are pursuing this.
LP made very clear they still have to do a global economic model in order to make a reimbursement request through the NICE STA process. It’s not easy but she hoped the whole process might be completed within 12 or less months (I assume she was including decision in that time frame.)
Meanwhile, if you can’t put your global economic model immediately together because you are awaiting some data (perhaps from compassionate program), it may be they could pursue alternative “funding” like the CDF, while they await the ability to assimilate a global economic model which would allow them to request “reimbursement.” IMHO.
Funding is different than reimbursement. Hopefully they are pursuing this.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
